Trade Alert: Healthcare

Taking advantage of today's drop.

Healthcare Threw Us A Curveball Today

Last week, we rolled the dice on a large managed‑care giant after a cluster of C‑suite buys suggested the bottom might be in. The company just reported: revenue surprised on the upside, earnings missed, guidance nudged lower—and the market punished the stock. That stumble, along with a lackluster print from Novo Nordisk (NVO 0.00%↑) this morning, sent shockwaves through the entire healthcare complex.

When everyone heads for the exits, we start shopping.

Today’s pullback opened a rare window to initiate three fresh bullish positions:

• A regenerative‑medicine pure play—the same early‑stage innovator we highlighted earlier this year for its quest to cure Type 1 diabetes with engineered cells.

• A second shot at an AI‑meets‑healthcare disrupter—think genomic sequencing, clinical data, and large‑language‑model smarts rolled into one.

• A first‑time wager on a blue‑chip drug powerhouse with arguably the strongest long‑duration growth asset in all of pharma.

I’ve structured each trade to cap downside and leave plenty of room for upside surprise; details are in the paid subscriber section below.

Today’s First Healthcare Trade